A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer
A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer
Recruiting · NCT07407283 · Registry updated 2026-04-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 / Phase 2 | 2026-04-21 | NCT07407283 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jiangsu HengRui Medicine Co., Ltd. | 132 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Second Hospital of Tianjin Medical University | Tianjin | China | 23 |
| West China Hospital of Sichuan University | Chengdu | China | 117 |